tiprankstipranks
Swedish Orphan Biovitrum AB (GB:0MTD)
LSE:0MTD
UK Market

Swedish Orphan Biovitrum AB (0MTD) Financial Statements

Compare
2 Followers

Swedish Orphan Biovitrum AB Financial Overview

Swedish Orphan Biovitrum AB's market cap is currently kr100.59B. The company's EPS TTM is kr11.35; its P/E ratio is 26.03; Swedish Orphan Biovitrum AB is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is kr2.66. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 26.03Bkr 22.12Bkr 18.79Bkr 15.53Bkr 15.26B
Gross Profitkr 20.24Bkr 17.13Bkr 14.01Bkr 12.04Bkr 12.04B
Operating Incomekr 5.63Bkr 4.07Bkr 3.81Bkr 3.73Bkr 4.82B
EBITDAkr 9.30Bkr 7.23Bkr 6.05Bkr 5.71Bkr 6.73B
Net Incomekr 3.88Bkr 2.41Bkr 2.64Bkr 2.68Bkr 3.25B
Balance Sheet
Cash & Short-Term Investmentskr 1.14Bkr 904.00Mkr 1.36Bkr 1.04Bkr 404.00M
Total Assetskr 75.44Bkr 74.03Bkr 52.50Bkr 48.66Bkr 48.28B
Total Debtkr 16.73Bkr 20.48Bkr 9.10Bkr 10.91Bkr 14.57B
Net Debtkr 15.60Bkr 19.58Bkr 7.74Bkr 9.86Bkr 14.17B
Total Liabilitieskr 35.15Bkr 40.16Bkr 25.97Bkr 25.46Bkr 28.08B
Stockholders' Equitykr 40.29Bkr 33.87Bkr 26.52Bkr 23.20Bkr 20.21B
Cash Flow
Free Cash Flowkr 4.38Bkr -473.00Mkr 3.19Bkr 5.10Bkr 1.36B
Operating Cash Flowkr 7.39Bkr 4.47Bkr 4.67Bkr 5.47Bkr 5.21B
Investing Cash Flowkr -3.09Bkr -21.90Bkr -1.48Bkr -367.00Mkr -3.96B
Financing Cash Flowkr -4.00Bkr 17.01Bkr -2.99Bkr -4.47Bkr -1.57B
Currency in SEK

Swedish Orphan Biovitrum AB Earnings and Revenue History

Swedish Orphan Biovitrum AB Debt to Assets

Swedish Orphan Biovitrum AB Cash Flow

Swedish Orphan Biovitrum AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis